Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Prospects for oral replicating adenovirus-vectored vaccines.

Deal C, Pekosz A, Ketner G.

Vaccine. 2013 Jul 11;31(32):3236-43. doi: 10.1016/j.vaccine.2013.05.016. Epub 2013 May 22. Review.

2.

Tropism-modification strategies for targeted gene delivery using adenoviral vectors.

Coughlan L, Alba R, Parker AL, Bradshaw AC, McNeish IA, Nicklin SA, Baker AH.

Viruses. 2010 Oct;2(10):2290-355. doi: 10.3390/v2102290. Epub 2010 Oct 13.

3.

In vivo retargeting of adenovirus type 5 to alphavbeta6 integrin results in reduced hepatotoxicity and improved tumor uptake following systemic delivery.

Coughlan L, Vallath S, Saha A, Flak M, McNeish IA, Vassaux G, Marshall JF, Hart IR, Thomas GJ.

J Virol. 2009 Jul;83(13):6416-28. doi: 10.1128/JVI.00445-09. Epub 2009 Apr 15.

4.

Genetically modified adenoviral vector with the protein transduction domain of Tat improves gene transfer to CAR-deficient cells.

Liu S, Mao Q, Zhang W, Zheng X, Bian Y, Wang D, Li H, Chai L, Zhao J, Xia H.

Biosci Rep. 2009 Apr;29(2):103-9. doi: 10.1042/BSR20080023.

5.

Adenoviral gene therapy, radiation, and prostate cancer.

Lupold SE, Rodriguez R.

Rev Urol. 2005 Fall;7(4):193-202.

6.

The Arg279Gln [corrected] substitution in the adenovirus type 11p (Ad11p) fiber knob abolishes EDTA-resistant binding to A549 and CHO-CD46 cells, converting the phenotype to that of Ad7p.

Gustafsson DJ, Segerman A, Lindman K, Mei YF, Wadell G.

J Virol. 2006 Feb;80(4):1897-905. Erratum in: J Virol. 2006 May;80(10):5101.

7.
8.

Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob.

Krasnykh V, Dmitriev I, Mikheeva G, Miller CR, Belousova N, Curiel DT.

J Virol. 1998 Mar;72(3):1844-52.

9.

Supplemental Content

Support Center